TY - JOUR
T1 - Multiple capsid-stabilizing interactions revealed in a high-resolution structure of an emerging picornavirus causing neonatal sepsis
AU - Shakeel, Shabih
AU - Westerhuis, Brenda M.
AU - Domanska, Ausra
AU - Koning, Roman I.
AU - Matadeen, Rishi
AU - Koster, Abraham J.
AU - Bakker, Arjen Q.
AU - Beaumont, Tim
AU - Wolthers, Katja C.
AU - Butcher, Sarah J.
PY - 2016
Y1 - 2016
N2 - The poorly studied picornavirus, human parechovirus 3 (HPeV3) causes neonatal sepsis with no therapies available. Our 4.3-angstrom resolution structure of HPeV3 on its own and at 15 angstrom resolution in complex with human monoclonal antibody Fabs demonstrates the expected picornavirus capsid structure with three distinct features. First, 25% of the HPeV3 RNA genome in 60 sites is highly ordered as confirmed by asymmetric reconstruction, and interacts with conserved regions of the capsid proteins VP1 and VP3. Second, the VP0 N terminus stabilizes the capsid inner surface, in contrast to other picornaviruses where on expulsion as VP4, it forms an RNA translocation channel. Last, VP1's hydrophobic pocket, the binding site for the antipicornaviral drug, pleconaril, is blocked and thus inappropriate for antiviral development. Together, these results suggest a direction for development of neutralizing antibodies, antiviral drugs based on targeting the RNA-protein interactions and dissection of virus assembly on the basis of RNA nucleation
AB - The poorly studied picornavirus, human parechovirus 3 (HPeV3) causes neonatal sepsis with no therapies available. Our 4.3-angstrom resolution structure of HPeV3 on its own and at 15 angstrom resolution in complex with human monoclonal antibody Fabs demonstrates the expected picornavirus capsid structure with three distinct features. First, 25% of the HPeV3 RNA genome in 60 sites is highly ordered as confirmed by asymmetric reconstruction, and interacts with conserved regions of the capsid proteins VP1 and VP3. Second, the VP0 N terminus stabilizes the capsid inner surface, in contrast to other picornaviruses where on expulsion as VP4, it forms an RNA translocation channel. Last, VP1's hydrophobic pocket, the binding site for the antipicornaviral drug, pleconaril, is blocked and thus inappropriate for antiviral development. Together, these results suggest a direction for development of neutralizing antibodies, antiviral drugs based on targeting the RNA-protein interactions and dissection of virus assembly on the basis of RNA nucleation
U2 - https://doi.org/10.1038/ncomms11387
DO - https://doi.org/10.1038/ncomms11387
M3 - Article
C2 - 27435188
SN - 2041-1723
VL - 7
SP - 11387
JO - Nature communications
JF - Nature communications
ER -